Abstract 2339: Prevalence of MET expression, activating mutations of KRAS and IDH1/2, and ROS1 fusions in cholangiocarcinoma patient tumor samples.Megan N. Thobe, Richard A. Walgren, Kelly M. Credille et al.|Cancer Research|2013Cited by 3
The Ron receptor tyrosine kinase in prostate cancer.Megan N. Thobe|OhioLink ETD Center (Ohio Library and Information Network)|2010Cited by 0